Cargando...
DNA damage repair in ovarian cancer: unlocking the heterogeneity
Treatment for advanced ovarian cancer is rarely curative; three quarters of patients with advanced disease relapse and ultimately die with resistant disease. Improving patient outcomes will require the introduction of new treatments and better patient selection. Abrogations in the DNA damage respons...
Gardado en:
| Publicado en: | J Ovarian Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6011341/ https://ncbi.nlm.nih.gov/pubmed/29925418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-018-0424-x |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|